MAPK6 and head and neck neoplasm: Based on database analysis, we found that the expression of MAPK6 was increased in head and neck tumor tissues, and our clinical samples also confirmed that the expression of MAPK6 was increased in LSCC, and the high expression of MAPK6 was positively correlated with the poor prognosis of tumor patients.